This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/515841-ramaphosa-johnson-covid19-vaccine-astrazeneca/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| ‘Quick, easy and not so painful’: S. Africa’s Ramaphosa gets J&J Covid jab as nation turns back on AstraZeneca | ‘Quick, easy and not so painful’: S. Africa’s Ramaphosa gets J&J Covid jab as nation turns back on AstraZeneca |
| (7 months later) | |
| South Africa’s president has been vaccinated with Johnson & Johnson’s Covid-19 jab, joining thousands of healthcare workers taking part in a trial to test the efficacy of the single-dose vaccine against the local virus variant. | South Africa’s president has been vaccinated with Johnson & Johnson’s Covid-19 jab, joining thousands of healthcare workers taking part in a trial to test the efficacy of the single-dose vaccine against the local virus variant. |
| President Cyril Ramaphosa urged his fellow South Africans to come forward and get a Covid-19 vaccine when it’s their turn in an online video of himself receiving the jab on Wednesday. | President Cyril Ramaphosa urged his fellow South Africans to come forward and get a Covid-19 vaccine when it’s their turn in an online video of himself receiving the jab on Wednesday. |
| Ramaphosa described the procedure as “quick, easy and not so painful”, and said that he had opted to take it so as to help “allay any fears that people may have” over it. | Ramaphosa described the procedure as “quick, easy and not so painful”, and said that he had opted to take it so as to help “allay any fears that people may have” over it. |
| The inoculation makes the president one of the first people to receive Johnson & Johnson’s vaccine outside of clinical trial conditions. | The inoculation makes the president one of the first people to receive Johnson & Johnson’s vaccine outside of clinical trial conditions. |
| In a series of tweets on Wednesday, Ramaphosa announced that the first batch of Johnson & Johnson’s vaccines had arrived in South Africa and would be administered, as planned, to healthcare workers later in the day. | In a series of tweets on Wednesday, Ramaphosa announced that the first batch of Johnson & Johnson’s vaccines had arrived in South Africa and would be administered, as planned, to healthcare workers later in the day. |
| The shots, which have not yet been approved for widespread use anywhere in the world, will be initially used as part of a trial in which no placebos are given. So far, more than 380,000 healthcare workers in South Africa have registered to receive the jab. | The shots, which have not yet been approved for widespread use anywhere in the world, will be initially used as part of a trial in which no placebos are given. So far, more than 380,000 healthcare workers in South Africa have registered to receive the jab. |
| The decision to start using the Johnson & Johnson vaccine comes as the country looks to offload its 1 million AstraZeneca doses. Pretoria turned its back on the AstraZeneca vaccine in early February after a small-scale study led by a South African university suggested that the jab was ineffective against the dominant strain of Covid-19 in the country. | The decision to start using the Johnson & Johnson vaccine comes as the country looks to offload its 1 million AstraZeneca doses. Pretoria turned its back on the AstraZeneca vaccine in early February after a small-scale study led by a South African university suggested that the jab was ineffective against the dominant strain of Covid-19 in the country. |
| AstraZeneca has questioned the thoroughness of the study in which none of the 2,000 participants were hospitalized with severe symptoms or died, but 39 eventually caught the virus – 19 from the vaccine group and 20 from the placebo group. The study prompted Pretoria to halt the jab’s rollout. | AstraZeneca has questioned the thoroughness of the study in which none of the 2,000 participants were hospitalized with severe symptoms or died, but 39 eventually caught the virus – 19 from the vaccine group and 20 from the placebo group. The study prompted Pretoria to halt the jab’s rollout. |
| On Tuesday, South Africa announced it would attempt to recoup some of its costs by “sharing” the jab with other countries in Africa. | On Tuesday, South Africa announced it would attempt to recoup some of its costs by “sharing” the jab with other countries in Africa. |
| Like this story? Share it with a friend! | Like this story? Share it with a friend! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |